* Cue Health Inc HLTH.OQ HLTH.O is expected to show a
fall in
quarterly revenue when it reports results on March 15.
* The San Diego California-based company is expected to
report a
75.2% decrease in revenue to $47.773 million from $192.51
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Cue Health Inc is
for a
loss of 45 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cue Health
Inc is
$6.5, above its last closing price of $1.79.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.54 -0.54 -0.45 Beat 17.1
Jun. 30 2022 -0.47 -0.46 -0.37 Beat 20
Mar. 31 2022 -0.05 -0.05 0.02 Beat 138.1
Dec. 31 2021 0.10 0.11 0.22 Beat 109.5
Sep. 1.48 1.48 0.13 Missed -91.2
30 2021
This summary was machine generated March 13 at 21:06 GMT. All
figures in US dollars unless otherwise stated